QR code

Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia

Abstract: Venetoclax is approved for older untreated acute myeloid leukemia (AML) patients. Venetoclax was available prior to approval off-label. We assessed our single-institution off-label experience with venetoclax/azacitidine, comparing outcomes with a clinical trial cohort that administered thi...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Amanda C. Winters, Jonathan A. Gutman, Enkhtsetseg Purev, Molly Nakic, Jennifer Tobin, Stephanie Chase, Jeff Kaiser, Lindsey Lyle, Chelsey Boggs, Keri Halsema, Jeffrey T. Schowinsky, Julie Rosser, Mark D. Ewalt, Bradford Siegele, Vishal Rana, Steven Schuster, Diana Abbott, Brett M. Stevens, Craig T. Jordan, Clayton Smith, Daniel A. Pollyea
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Elsevier 2019-10-01
Reeks:Blood Advances
Online toegang:http://www.sciencedirect.com/science/article/pii/S2473952920318115
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items